Dr. Jamie K. Waselenko, MD, FACP

Expert Publications

• Stem-cell transplantation in chronic lymphocytic leukemia: the time for designing randomized studies has arrived.
• Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature.
• Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation.
• Medical management of radiological casualties.
• Management of progressive metastatic prostate cancer.

Media Releases

Get to know Oncologist Dr. Jamie K. Waselenko, who serves patients in Cincinnati, Ohio.

Dr. Waselenko (or Dr. Jamie as her patients like to call her) is a well-versed oncologist whose areas of interest include general medical oncology, lymphomas, leukemias, and myeloma. She sees patients at The Christ Hospital Outpatient Center – Anderson & The Christ Hospital Outpatient Center – Red Bank.

Bringing over 18 years of hematology and medical oncology experience to the Christ program and Cincinnati area, Dr. Waselenko offers a unique approach, utilizing personalized, faith-based medicine in her practice to provide state-of-the-art care to patients with both blood disorders and cancer. She sees patients with virtually all facets of blood and cancer diagnoses. She also offers prayer to patients and families at their request. 

Born in Kentucky, Dr. Waselenko grew up in Michigan, receiving her undergraduate degree in Biology at Wayne State University in 1988 and graduating with high honors. She then attended medical school while serving in the US Army at the F. Edward Hébert School of Medicine at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Her academic achievements include being selected into Phi Beta Kappa and Alpha Omega Alpha Medical Honor Societies because of her undergraduate and graduate accomplishments. 

Wanting to further her education, she went on to complete her internship in internal medicine at the Walter Reed Army Medical Center, her residency in internal medicine at the Madigan Army Medical Center, and her fellowship in hematology and oncology at the Walter Reed Army Medical Center. She received additional post-graduate training in translational research and bone marrow transplantation at Johns Hopkins Medical Center in Baltimore. She then served at two of the Army’s teaching hospitals, Walter Reed Army Medical Center and Brooke Army Medical Center in San Antonio, Texas. 

Proudly serving in the US Army for 17 years, Dr. Waselenko thoroughly enjoyed caring for military beneficiaries. After completing her service obligation, she left the Army to join the research team at Sarah Cannon Research Institute and Tennessee Oncology to develop a leukemia program and to lead a team in the development of a new stem cell transplant program. While there, she became Clinical Director of the Sarah Cannon Blood and Marrow Transplant Program as well as Director of Leukemia Research at the Sarah Cannon Research Institute. 

A Fellow of the American College of Physicians (FACP), the doctor is board-certified in medical oncology, hematology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Still involved in clinical trials through The Christ Hospital, Dr. Waselenko has conducted research and has been published in the areas of leukemia, lymphoma, stem cell transplantation, and the management of acute radiation syndrome. She holds membership status with the American Society of Clinical Oncology, the Alpha Omega Alpha Medical Honor Society, and the American Society of Hematology.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with radiation therapy, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

On a more personal note, Dr. Waselenko is very active with her church and periodically joins others in mission work around the globe. She enjoys reading, serving others, and spending time w

Recommended Articles

• Survey Shows Lack of Blood Cancer Knowledge Among Americans

  If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...

• The Link Between Melatonin and Lymphoma

  There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...

• 'Robocop' Stem Cells Developed to Fight Cancer

  Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...